PT3110961T - Modulação do crescimento celular e da glicosilação na produção de glicoproteínas recombinantes - Google Patents

Modulação do crescimento celular e da glicosilação na produção de glicoproteínas recombinantes

Info

Publication number
PT3110961T
PT3110961T PT157094301T PT15709430T PT3110961T PT 3110961 T PT3110961 T PT 3110961T PT 157094301 T PT157094301 T PT 157094301T PT 15709430 T PT15709430 T PT 15709430T PT 3110961 T PT3110961 T PT 3110961T
Authority
PT
Portugal
Prior art keywords
glycosylation
modulation
cell growth
recombinant glycoprotein
glycoprotein production
Prior art date
Application number
PT157094301T
Other languages
English (en)
Portuguese (pt)
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=50184787&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT3110961(T) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of PT3110961T publication Critical patent/PT3110961T/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018Culture media for cell or tissue culture
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/38Chemical stimulation of growth or activity by addition of chemical compounds which are not essential growth factors; Stimulation of growth by removal of a chemical compound
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/005Glycopeptides, glycoproteins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/40Immunoglobulins specific features characterized by post-translational modification
    • C07K2317/41Glycosylation, sialylation, or fucosylation

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
PT157094301T 2014-02-27 2015-02-24 Modulação do crescimento celular e da glicosilação na produção de glicoproteínas recombinantes PT3110961T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP14157030 2014-02-27

Publications (1)

Publication Number Publication Date
PT3110961T true PT3110961T (pt) 2020-01-29

Family

ID=50184787

Family Applications (1)

Application Number Title Priority Date Filing Date
PT157094301T PT3110961T (pt) 2014-02-27 2015-02-24 Modulação do crescimento celular e da glicosilação na produção de glicoproteínas recombinantes

Country Status (20)

Country Link
US (3) US20170058309A1 (enExample)
EP (1) EP3110961B1 (enExample)
JP (2) JP6831702B2 (enExample)
KR (1) KR102280638B1 (enExample)
CN (1) CN106133146B (enExample)
BR (1) BR112016017660B1 (enExample)
CA (1) CA2937611C (enExample)
DK (1) DK3110961T3 (enExample)
ES (1) ES2769003T3 (enExample)
HR (1) HRP20200100T1 (enExample)
HU (1) HUE047575T2 (enExample)
LT (1) LT3110961T (enExample)
MX (1) MX369395B (enExample)
PL (1) PL3110961T3 (enExample)
PT (1) PT3110961T (enExample)
RS (1) RS59881B1 (enExample)
RU (1) RU2712562C2 (enExample)
SG (1) SG11201606856SA (enExample)
SI (1) SI3110961T1 (enExample)
WO (1) WO2015128314A1 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013078106A1 (en) 2011-11-21 2013-05-30 Nonomura Arthur M Methods and systems for growing plants using silicate-based substrates, cultivation of enhanced photosynthetic productivity and photosafening by utilization of exogenous glycopyranosides for endogenous glycopyranosyl-protein derivatives, and formulations, processes and systems for the same
SI3110961T1 (sl) * 2014-02-27 2020-03-31 F. Hoffmann-La Roche Ag Modulacija rasti celic in glikozilacije pri rekombinantni proizvodnji glikoproteina
AU2015355087C1 (en) * 2014-12-01 2025-10-30 Amgen Inc. Process for manipulating the level of glycan content of a glycoprotein
US11013234B2 (en) * 2016-04-29 2021-05-25 Innovation Hammer Llc Formulations and methods for treating photosynthetic organisms and enhancing qualities and quantities of yields with glycan composite formulations
US12503700B2 (en) 2017-03-14 2025-12-23 Amgen Inc. Control of total afucosylated glycoforms of antibodies produced in cell culture
WO2019077628A1 (en) * 2017-10-16 2019-04-25 Council Of Scientific & Industrial Research ZINC SUPPLEMENTATION TO DECREASE GALACTOSYLATION OF RECOMBINANT GLYCOPROTEINS
KR20250016476A (ko) * 2018-03-16 2025-02-03 젠자임 코포레이션 생산용 생물 반응기에서의 세포 생존력을 개선하는 방법
SG11202009216YA (en) 2018-03-26 2020-10-29 Amgen Inc Total afucosylated glycoforms of antibodies produced in cell culture
CA3099917A1 (en) * 2018-05-24 2019-11-28 Ares Trading S.A. Method for controlling the afucosylation level of a glycoprotein composition
HU231514B1 (hu) 2018-11-07 2024-07-28 Richter Gedeon Nyrt. Sejttenyészetben előállított rekombináns glikoprotein glikozilációs mintázatának megváltoztatására szolgáló módszer
US11634499B2 (en) * 2018-11-13 2023-04-25 Janssen Biotech, Inc. Control of trace metals during production of anti-CD38 antibodies
JP2020188737A (ja) * 2019-05-23 2020-11-26 東ソー株式会社 抗体依存性細胞傷害活性が向上した抗体の製造方法
CR20220531A (es) * 2020-04-24 2022-11-28 Hoffmann La Roche Modulacion de enzimas y vías con compuestos de sulfhidrilo y sus derivados
WO2025036924A1 (en) * 2023-08-16 2025-02-20 Glaxosmithkline Intellectual Property Limited Method of controlling antibody glycosylation profile

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4767704A (en) 1983-10-07 1988-08-30 Columbia University In The City Of New York Protein-free culture medium
IL87737A (en) 1987-09-11 1993-08-18 Genentech Inc Method for culturing polypeptide factor dependent vertebrate recombinant cells
US5705364A (en) * 1995-06-06 1998-01-06 Genentech, Inc. Mammalian cell culture process
US6030945A (en) 1996-01-09 2000-02-29 Genentech, Inc. Apo-2 ligand
EP2218775B1 (en) 1996-08-30 2015-01-28 Life Technologies Corporation Method for producing a polypeptide in vitro in mammalian cells in a protein-free and serum-free culture medium
DE69929198T2 (de) * 1998-05-29 2006-08-10 Genentech, Inc., South San Francisco Zellkulturverfahren für die produktion von glycoproteinen
JP2001120262A (ja) 1999-10-26 2001-05-08 Welfide Corp 生理活性物質の産生増強方法
DE60230858D1 (de) 2001-02-15 2009-03-05 Centocor Inc Chemisch definiertes medium für kultivierte säugerzellen
US20050287666A1 (en) * 2004-06-29 2005-12-29 Invitrogen Corporation Cell culture medium comprising transition metals or trace elements
TWI384069B (zh) 2004-08-27 2013-02-01 Pfizer Ireland Pharmaceuticals 多胜肽之製法
ES2361559T3 (es) 2004-11-02 2011-06-20 Ares Trading S.A. Medio de cultivo de células exento de suero para mamíferos.
US20070231895A1 (en) 2005-11-02 2007-10-04 Lee Gene W Methods for adapting mammalian cells
EP2495308A1 (en) 2005-12-08 2012-09-05 Amgen Inc. Improved production of glycoproteins using manganese
ES2440487T3 (es) 2006-07-13 2014-01-29 Wyeth Llc Producción de glucoproteínas
US8192951B2 (en) 2006-11-03 2012-06-05 Wyeth Llc Glycolysis-inhibiting substances in cell culture
EP2924113B1 (en) 2007-03-02 2019-04-10 Wyeth LLC Use of copper and glutamate in cell culture for production of polypeptides
US20110053223A1 (en) * 2009-08-14 2011-03-03 Robert Bayer Cell culture methods to make antibodies with enhanced adcc function
US20120309056A1 (en) * 2010-02-04 2012-12-06 Leon Arnaud Fed-batch process using concentrated cell culture medium for the efficient production of biologics in eb66 cells
CN102858954A (zh) 2010-04-26 2013-01-02 诺瓦提斯公司 改进的细胞培养方法
US9062106B2 (en) 2011-04-27 2015-06-23 Abbvie Inc. Methods for controlling the galactosylation profile of recombinantly-expressed proteins
CN105189735B (zh) 2011-04-29 2019-04-12 拜康研究有限公司 在培养期间减少乳酸累积的方法和生产多肽的方法
US10059770B2 (en) 2012-01-30 2018-08-28 Dr. Reddy's Laboratories Limited Process of modulating man5 and/or afucosylation content of a glycoprotein composition
EP3052640A2 (en) 2013-10-04 2016-08-10 AbbVie Inc. Use of metal ions for modulation of protein glycosylation profiles of recombinant proteins
SI3110961T1 (sl) * 2014-02-27 2020-03-31 F. Hoffmann-La Roche Ag Modulacija rasti celic in glikozilacije pri rekombinantni proizvodnji glikoproteina

Also Published As

Publication number Publication date
BR112016017660B1 (pt) 2022-04-19
DK3110961T3 (da) 2020-02-03
MX2016010236A (es) 2016-10-13
RS59881B1 (sr) 2020-03-31
KR102280638B1 (ko) 2021-07-22
CA2937611A1 (en) 2015-09-03
CN106133146B (zh) 2021-05-04
SI3110961T1 (sl) 2020-03-31
US20170058309A1 (en) 2017-03-02
BR112016017660A2 (enExample) 2017-08-08
CN106133146A (zh) 2016-11-16
RU2016138176A3 (enExample) 2018-10-29
MX369395B (es) 2019-11-07
WO2015128314A1 (en) 2015-09-03
JP6934507B2 (ja) 2021-09-15
KR20160125514A (ko) 2016-10-31
CA2937611C (en) 2023-01-03
LT3110961T (lt) 2020-02-10
HUE047575T2 (hu) 2020-04-28
JP6831702B2 (ja) 2021-02-17
EP3110961B1 (en) 2019-11-27
JP2017506515A (ja) 2017-03-09
US20210222220A1 (en) 2021-07-22
EP3110961A1 (en) 2017-01-04
ES2769003T3 (es) 2020-06-24
RU2712562C2 (ru) 2020-01-29
US20240327890A1 (en) 2024-10-03
PL3110961T3 (pl) 2020-04-30
RU2016138176A (ru) 2018-03-29
HRP20200100T1 (hr) 2020-04-03
SG11201606856SA (en) 2016-09-29
JP2020054351A (ja) 2020-04-09

Similar Documents

Publication Publication Date Title
SG11201606856SA (en) Modulation of cell growth and glycosylation in recombinant glycoprotein production
IL253248A0 (en) Natural killer cells and their uses
SG11201609118RA (en) Modified natural killer cells and uses thereof
SG10201912576PA (en) Natural killer cells and ilc3 cells and uses thereof
ZA201605308B (en) Plant growth promoting rhizobacterial strains and their uses
ZA201704595B (en) Methods of producing long acting ctp-modified growth hormone polypeptides
EP3215602A4 (en) Methods and materials for producing recombinant viruses in eukaryotic microalgae
IL263779A (en) Protein production in plant cells
DK3242935T3 (da) O-glycansialylerede rekombinante glycoproteiner og cellelinjer til fremstilling deraf
EP2971035A4 (en) RECOMBINED POLYPEPTIDE PRODUCTION
EP3322429B8 (en) Growth promoting peptides and uses thereof
IL250530A0 (en) Production of functional and fully processed factor x in a mammalian purine-secreting expression system
IL247776B (en) Methods for the production of recombinant glycoproteins with adapted glycosylation
ZA201700867B (en) Modifying protein production in plants
SI3289088T1 (sl) Odklop rasti in proizvodnja proteina
IL240639A0 (en) Formulations and methods for increased recombinant production of protein
GB2517846B (en) Improvements in and relating to loudspeakers
EP3108711A4 (en) Methods and arrangements to schedule communications
PL3158055T3 (pl) Ulepszone wytwarzanie rekombinowanego czynnika von Willebranda w bioreaktorze
IL258193A (en) Modified death-inducing cells with anti-pyotactic properties and their use
DE112015003749A5 (de) Peptid zur verwendung in der reduktion von nebenwirkungen in form von immunstimulatorischen reaktionen/effekten
GB201308120D0 (en) Recombinant protein and method for its production
GB201308218D0 (en) Chlor-Alkali Process and Plant
GB2530075B (en) Improvements in and relating to eyewashing
GB201610164D0 (en) Modified natural killer cells and natural killer cell lines having increased cytoxicity